Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19.
Maeda R, Seki N, Uwamino Y, Wakui M, Nakagama Y, Kido Y, Sasai M, Taira S, Toriu N, Yamamoto M, Matsuura Y, Uchiyama J, Yamaguchi G, Hirakawa M, Kim YG, Mishima M, Yanagita M, Suematsu M, Sugiura Y. Maeda R, et al. Among authors: wakui m. Nat Commun. 2023 Dec 20;14(1):8469. doi: 10.1038/s41467-023-44266-z. Nat Commun. 2023. PMID: 38123556 Free PMC article.
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.
Tani Y, Takita M, Wakui M, Saito H, Nishiuchi T, Zhao T, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Shinaha R, Tsubokura M. Tani Y, et al. Among authors: wakui m. Front Immunol. 2023 Aug 16;14:1240425. doi: 10.3389/fimmu.2023.1240425. eCollection 2023. Front Immunol. 2023. PMID: 37662950 Free PMC article.
SARS-CoV-2 spike protein antibody titers after the fourth dose of BNT162b2 vaccine among Japanese patients undergoing hemodialysis: a single-center study.
Watanabe S, Sawano T, Saito H, Ozaki A, Wakui M, Zhao T, Yamamoto C, Kobashi Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Shimmura H, Tsubokura M. Watanabe S, et al. Among authors: wakui m. Front Immunol. 2024 Aug 21;15:1412918. doi: 10.3389/fimmu.2024.1412918. eCollection 2024. Front Immunol. 2024. PMID: 39238641 Free PMC article.
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays.
Saito H, Yoshimura H, Yoshida M, Tani Y, Kawashima M, Uchiyama T, Zhao T, Yamamoto C, Kobashi Y, Sawano T, Imoto S, Park H, Nakamura N, Iwami S, Kaneko Y, Nakayama A, Kodama T, Wakui M, Kawamura T, Tsubokura M. Saito H, et al. Among authors: wakui m. Vaccines (Basel). 2023 Nov 7;11(11):1694. doi: 10.3390/vaccines11111694. Vaccines (Basel). 2023. PMID: 38006026 Free PMC article.
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
Nakamura N, Kobashi Y, Kim KS, Park H, Tani Y, Shimazu Y, Zhao T, Nishikawa Y, Omata F, Kawashima M, Yoshida M, Abe T, Saito Y, Senoo Y, Nonaka S, Takita M, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Jeong YD, Tatematsu D, Akao M, Sato Y, Iwanami S, Fujita Y, Wakui M, Aihara K, Kodama T, Shibuya K, Iwami S, Tsubokura M. Nakamura N, et al. Among authors: wakui m. PLOS Digit Health. 2024 May 3;3(5):e0000497. doi: 10.1371/journal.pdig.0000497. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38701055 Free PMC article.
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.
Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Saito H, Yamamoto C, Zhao T, Takita M, Ito N, Tatsuno K, Kaneko Y, Nakayama A, Kodama T, Wakui M, Takahashi K, Tsubokura M. Yoshida M, et al. Among authors: wakui m. Sci Rep. 2023 Jun 7;13(1):9264. doi: 10.1038/s41598-023-36429-1. Sci Rep. 2023. PMID: 37286720 Free PMC article.
Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan.
Zhao T, Tani Y, Makino-Okamura C, Takita M, Yamamoto C, Kawahara E, Abe T, Sugiura S, Yoshimura H, Uchiyama T, Yamazaki I, Ishigame H, Ueno T, Okuma K, Wakui M, Fukuyama H, Tsubokura M. Zhao T, et al. Among authors: wakui m. Front Immunol. 2024 Mar 18;15:1337520. doi: 10.3389/fimmu.2024.1337520. eCollection 2024. Front Immunol. 2024. PMID: 38562937 Free PMC article.
Group of longitudinal adverse event patterns after the fourth dose of COVID-19 vaccination with a latent class analysis.
Yamamoto C, Kobashi Y, Kawamura T, Nishikawa Y, Saito H, Oguro F, Zhao T, Takita M, Sawano T, Ozaki A, Abe T, Ito N, Kaneko Y, Nakayama A, Wakui M, Kodama T, Tsubokura M. Yamamoto C, et al. Among authors: wakui m. Front Public Health. 2024 Jul 30;12:1406315. doi: 10.3389/fpubh.2024.1406315. eCollection 2024. Front Public Health. 2024. PMID: 39139673 Free PMC article.
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.
Tani Y, Takita M, Kobashi Y, Wakui M, Zhao T, Yamamoto C, Saito H, Kawashima M, Sugiura S, Nishikawa Y, Omata F, Shimazu Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Kami M, Tsubokura M. Tani Y, et al. Among authors: wakui m. Vaccines (Basel). 2023 Apr 29;11(5):920. doi: 10.3390/vaccines11050920. Vaccines (Basel). 2023. PMID: 37243024 Free PMC article.
209 results